Abstract
Introduction
The hepatitis B vaccine is the backbone of hepatitis B prevention. All health care workers must receive a full-dose (3-dose vaccine series) to achieve >90% protection against hepatitis B virus. There is limited evidence available on vaccination coverage of HBV among health care workers in Ethiopia. Therefore, the objective of this study was to estimate the national full-dose hepatitis B vaccination coverage and the associated factors among health care workers in Ethiopia.
Methods
Studies were retrieved from PubMed, EMBASE, Web of Science, SCOPUS, CINAHL, and Google Scholar by using a combination of search terms with Boolean operators. The quality of each study was evaluated independently by three authors using the modified Newcastle-Ottawa Scale (NOS) for cross-sectional studies. Statistical analyses were performed using STATA™ Version 14 software. Meta-analysis was carried out using a random-effects (DerSimonian and Laird) method. The heterogeneity test was conducted by using I-squared (I2) statistics. Leave-one-out sensitivity analysis was performed.
Results
A total of 15 articles with 5734 participants were included in this systematic review and meta-analysis. The pooled prevalence of full-dose hepatitis B virus vaccination coverage among health care workers in Ethiopia was 20.04% (95% CI: 13.83, 26.26); I2 = 98.9%). Being male sex (p = 0.002), having work experience of less than 5 years (p < 0.001), educational level of diploma and below (p = 0.003), health care providers who received training on infection prevention (p < 0.001), and those who had a history of exposure to blood and body fluids (p = 0.001), were factors significantly associated with full-dose hepatitis B virus vaccination.
Conclusion
The national full-dose hepatitis B vaccination coverage among health care workers was low. Training of health care workers in infection prevention, particularly in hepatitis B and testing and providing hepatitis B vaccination for newly recruited staff and every 5 years for those long-term workers were recommended to increase the uptake of the vaccine.
Introduction
Hepatitis B is an infectious disease caused by a virus called the hepatitis B virus (HBV) and can cause both acute and chronic diseases [1]. Although there are different prevention strategies for hepatitis B, such as standard (universal) precautions and enhanced percutaneous injury precautions, such as double-gloving in surgery [2] the hepatitis B vaccine is the backbone of hepatitis B prevention [3]. The CDC recommends that all health care workers receive a 3-dose vaccine series with an approximate protection rate of 30%–55% after the first dose, 75% after the second dose, and >90% after the third dose in adults aged ≤40 years [4].
Hepatitis B virus infection is one of the serious challenging blood-borne occupational hazards among health care workers [5–9]. They are exposed to a higher risk of blood-borne pathogens and other body fluids, such as saliva, menstrual, vaginal, and seminal fluids, during their routine health care services [5, 6, 10]. The exposure might be a result of needle stick injuries, contamination with an infected patient's blood, a splashing of blood or other body fluids into the eyes, nose or mouth, or blood contact with non-intact skin [7, 10].
The estimated global prevalence of HBV in 2015 among the general population was 3.5%, with approximately 257 million persons living with HBV infection and 887 220 people’s dead in the same year [9]. In Africa, its prevalence was 6.1% in 2015, which was the highest across the globe [9]. Moreover, the prevalence of HBV ranged from 5% to 8% [11] in the Sub-Saharan region. Additionally, the estimated prevalence of hepatitis B virus (HBV) among the general population in Ethiopia was 6% [12].
HBV/HIV co-infection accounts approximately 5–20% of people infected with HIV even though it varies significantly between risk-based groups, regions and, reflecting different patterns of transmission [13]. In Sub Saharan Africa the prevalence of HIV/HBV co-infection was reported to be 15%; whereas in Ethiopia the documented prevalence of co infection hospital-based studies was 3. 9–14% [14].
Ethiopia launched an expanded program on immunization (EPI) with targeting children of under-one year of age and women of reproductive age group (15–49 years age) in 1980 comprising of with six antigens namely BCG, Diphtheria, pertussis, tetanus, polio and measles [15, 16]. In 2007 the government added Hepatitis B and Hib vaccines to the standard EPI schedule [16]. The immunization cost was largely covered by donors and the main funding partners were USAID, UNICEF and GAVI Alliance. Although, the government funds some traditional routine vaccine, such as TT, BCG, and 50% of Polio vaccine [16].
Compared to the general population the risk of HBV infection is fourfold greater among HCWs [9, 17]. Worldwide, there are approximately 35 million health workers [10]. Of these, approximately 5.9% of them were exposed to HBV every year [18]. The annual HBV infection rate is estimated to be 70 000, and more than 90% of these infections occur in developing countries [10]. The prevalence of HBV infection among health workers ranges from 0.8% to 74.4%, although it depends upon the region where they work [11]. In Ethiopia, the pooled national prevalence of HBV among health care workers is estimated to be 5% [12].
Different strategies and guidelines were implemented to reduce the risk of HBV infections among healthcare workers in Ethiopia; for instance, the Ethiopian Federal Ministry of Health (FMOH) infection-prevention guidelines recommend that all health care workers be vaccinated against HBV before they begin clinical attachments; Despite this the prevalence of hepatitis B vaccination remains low [19, 20].
Hepatitis B vaccination remains the most effective and feasible method to prevent HBV infection to and from HCWs and their patients [5, 6, 18]. The World Health Organization (WHO) recommended that all HCWs should be vaccinated against HBV [5]. However, approximately 24% of global health care workers remain unvaccinated [11]. According to the WHO report, only 18–39% of health care workers in low and middle–income countries (LMICs) received HBV vaccination as compared to 67–79% in high-income countries [21]. In the United States and China overall, 63.4% and 60% of HCW received complete ≥3 doses of hepatitis B vaccination respectively [18, 22]. In Africa, only a quarter of HCWs were fully vaccinated for HBV, with an estimated full hepatitis B vaccination coverage of 24.7% [6].
Although HBV vaccination is critical to prevent HBV infection among health care workers, limited evidence is available on vaccination coverage of HBV among health care workers in Ethiopia. Therefore, the objective of this study was to estimate the national full-dose hepatitis B vaccination (uptake of ≥3 doses of vaccine) coverage and the associated factors among health care workers in Ethiopia.
Materials and methods
Study design and search strategy
We systematically searched PubMed, EMBASE, Web of Science, SCOPUS, CINAHL, and Google Scholar for published articles. Unpublished studies were searched from the Addis Ababa University research repository. The core search terms and phrases were “Health care workers”, “Health care professionals”, “Hepatitis B vaccination”, “Hepatitis B vaccine”, “Vaccination status”, “Vaccination coverage”, “Hepatitis B antibody”, and “Ethiopia”
The following search terms with Boolean operators were used to search related articles: (((Health care workers OR Health Care Personnel OR health care providers OR health care professionals OR Nurse OR Medical doctors OR Midwifery OR Surgeon OR Midwife OR Physician OR Health office OR Lab technician OR General practitioner OR Pharmacist OR Specialist OR Dental doctor)) AND (Hepatitis B OR Hepatitis B status OR Hepatitis B vaccination coverage OR Hepatitis B vaccine OR uptake OR vaccination OR coverage OR immunization OR Hepatitis B virus OR Vaccines OR HBV OR Vaccination status OR Vaccination coverage OR Immune response OR vaccine efficacy OR Hepatitis B antibody)) AND Ethiopia
The report was written according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [23]. EndNote (version X8) reference management software for Windows was used to download, organize, review, and cite related articles.
Study selection and eligibility criteria
Publication status
We included both published and unpublished studies.
Study area
Ethiopia.
Language
Studies written in the English language.
Study period
Studies conducted or published from 2007 to April 30, 2020.
Study type
All observational studies reported the prevalence of complete vaccination against the hepatitis B virus among health care workers.
Study content
Studies that reported the prevalence of full-dose vaccination against the hepatitis B virus among health care workers.
Studies were excluded if:
Studies that did not report the prevalence of health care workers who take a full-dose of hepatitis B vaccination
Methodologically poor studies
Study extraction and quality appraisal
The data were extracted by three independent authors (N.A, H.M, and T.L) using a data extraction format prepared in a Microsoft Excel 2013 spreadsheet. The extracted data were: the first author’s name, publication year, region, design, sample size, sampling method, prevalence of full-dose vaccination against hepatitis B, and associated factors with their odds ratio. The quality of each study was assessed using the modified Newcastle-Ottawa Scale (NOS) for cross-sectional studies [24]. Studies were included with a score of 7 and more on the NOS. The quality of each study was evaluated independently by three authors (N.A, H.M, and T.L) and any disagreements that appeared during abstraction were resolved by discussion and consensus.
Outcome variable and operational definition
The outcome of this review was full-dose hepatitis B virus vaccination. Full-dose hepatitis B virus vaccination was defined as healthcare workers who had received three HBV vaccine doses intramuscularly at 0, 1, and 6 months [4].
Statistical analysis
Statistical analyses were performed using STATA™ Version 14 software. The heterogeneity test was conducted by using I-squared (I2) statistics. The value of I2 statistics ranges from 0 to 100% and 25, 50, and 75%, which represent low, medium, and high heterogeneity across the included studies, respectively [25]. The pooled prevalence of full-dose vaccination against the hepatitis B virus among health care workers was carried out using a random-effects (DerSimonian and Laird) method. To minimize the potential random variations between studies; the sources of heterogeneity were analyzed using subgroup analysis, and meta-regression. A leave-out-one sensitivity analysis was conducted by excluding each study at a time to identify the impact of each study on the overall estimate.
Study selection
Initially, 458 articles were retrieved through electronic online and manual searching. Of these, 13 duplicate articles were found and removed. Four hundred forty-five irrelevant articles were excluded by title and abstract screening. The remaining 39 full articles were assessed for eligibility; among them, 14 articles did not report the outcome of interest, 1 article with poor methodological quality and 9 articles that did not report the prevalence of health care providers who take a full-dose of hepatitis B vaccination were excluded. Finally, a total of 15 articles were included in the systematic review, and meta-analysis (Fig 1).
Fig 1. PRISMA flowchart diagram of the study selection.
Study characteristics
A total of 15 articles with 5734 participants were included in this systematic review and meta-analysis. All the included studies were cross-sectional studies and the sample size ranged from 232 [26] to 1125 [27]. Regarding the regional distribution of the included studies, 4 were conducted in the Oromia region [26, 28–30], 3 in the Amhara region [22, 27, 31], 5 in Addis Ababa [33–37], 2 in the Southern Nations, Nationalities and Peoples Region (SNNPR) [38, 39], and 1 study in Diredawa [40]. Among the included studies, the prevalence of full-dose hepatitis B vaccination coverage among health care workers ranged from 1.3 [26] to 62.7 [38] (Table 1)
Table 1. Characteristics of the included studies in the systematic review and meta-analysis for the prevalence of full-dose hepatitis B vaccination coverage among health care workers in Ethiopia, 2020.
| No | Author/s name (Reference) | Publication year | Study area | Region | Study design | Sample size | NOS | Prevalence %(95%CI |
|---|---|---|---|---|---|---|---|---|
| 1 | Abebaw T. et al., [28] | 2017 | Shashemene | Oromia | Cross sectional | 423 | 9 | 12.9 (9.71, 16.09) |
| 2 | Abeje G. and Azage M. [31] | 2015 | Bahirdar city | Amhara | Cross sectional | 370 | 8 | 5.4 (3.09, 7.70) |
| 3 | Afework G. [33] | 2015 | Addis Ababa | Addis Ababa | Cross sectional | 240 | 7 | 4.4 (1.81, 6.99) |
| 4 | Akibu M. et al. [29] | 2018 | Adama | Oromia | Cross sectional | 386 | 9 | 25.6 (21.25, 29.95) |
| 5 | Bante A. et al. [38] | 2018 | W/Sodo | SNNPR | Cross sectional | 370 | 8 | 62.7 (57.77, 67.63) |
| 6 | Bedaso A. et al., [39] | 2018 | Hawassa | SNNPR | Cross sectional | 241 | 8 | 21.9 (16.68, 27.12) |
| 7 | Belete T. [34] | 2016 | Addis Ababa | Addis Ababa | Cross sectional | 394 | 8 | 16.5 (12.83, 20.17) |
| 8 | Biset A. and Adugna H. [32] | 2017 | Gonder | Amhara | Cross sectional | 286 | 9 | 28.7 (23.46, 33.94) |
| 9 | Dugassa M., [30] | 2018 | East Wollega | Oromia | Cross sectional | 500 | 9 | 34.2 (30.04, 38.36) |
| 10 | Feleke B. [27] | 2016 | Amhara | Amhara | Cross sectional | 1125 | 9 | 4.0 (2.86, 5.15) |
| 11 | Girma T. [26] | 2015 | West Hararghe | Oromia | Cross sectional | 232 | 8 | 1.3 (0.16, 2.76) |
| 12 | Lateef I. [35] | 2018 | Addis Ababa | Addis Ababa | Cross sectional | 300 | 9 | 40.3 (34.75, 45.85) |
| 13 | Mekonnen R. et al. [40] | 2018 | Dire dawa | Dire dawa | Cross sectional | 282 | 8 | 36.2 (30.59, 41.81) |
| 14 | Taddesse G. et al., [36] | 2016 | Addis Ababa | Addis Ababa | Cross sectional | 313 | 9 | 1.6 (0.21, 2.99) |
| 15 | Yimer S. et al. [37] | 2017 | Addis Ababa | Addis Ababa | Cross sectional | 272 | 8 | 8.8 (5.43, 12.17) |
Prevalence of full-dose hepatitis B vaccination coverage among health care workers
A DerSimonian and Laird random-effects model was fitted to determine the pooled effect size. Accordingly, the national pooled prevalence of full-dose hepatitis B vaccination coverage among health care workers with a random-effects model was 20.04% (95% CI: 13.83, 26.26) with a heterogeneity index (I2) of 98.9% (p < 0.001) (Fig 2).
Fig 2. Forest plot showing the pooled prevalence of full-dose hepatitis B vaccination coverage among health care providers in Ethiopia.
Subgroup analysis
Since this meta-analysis showed a considerable heterogeneity, subgroup analysis was done using region where the studies were conducted. Based on this, the highest (42.33%; 95% CI: 2.33, 82.29), I2 = 97.5%) and the lowest (12.16%; 95% CI: 3.39, 20.92), I2 = 97.5%) prevalence of HBV full-dose vaccination among healthcare workers was observed in the SNNPR and Amhara region, respectively. In Oromia region pooled prevalence of full-dose hepatitis B vaccination coverage was 18.42% (95% CI: 3.18, 33.65) with a heterogeneity index (I2) of 99.9% (p < 0.001). In Addis Ababa the documented prevalence was 14.02% (95% CI: 4.65, 23.38) with a heterogeneity index (I2) of 98.2% (p < 0.001) (Fig 3).
Fig 3. Subgroup analysis of full-dose hepatitis B vaccination coverage among health care providers by region in Ethiopia.
Heterogeneity and publication bias
To adjust and minimize the reported heterogeneity of this study (I2 = 98.9%), we performed a subgroup analysis based on the region in Ethiopia. Meta-regression was also conducted to identify the source of heterogeneity using sample size and year of publication as a covariate. It was indicated that there was no effect of sample size and year of publication on heterogeneity between studies (Table 2). The presence of publication bias was tested by Egger’s test, and graphically by a funnel plot. Visual inspection of the funnel plot indicated asymmetrical distribution (Fig 4), which is statistically significant as evidenced by the Egger test (p < 0.001). Therefore, trim and fill analysis using the random-effects model was performed to determine the final effect size. However, a similar effect size was obtained using the model. Furthermore, we executed sensitivity analysis by removing studies step by step to evaluate the effect of a single study on the overall effect estimate. The results indicated that removing a single study did not have a significant influence on pooled prevalence (Table 3).
Table 2. Meta-regression analysis of factors affecting between-study heterogeneity.
| Heterogeneity source | Coefficients | Std. Err. | P-value |
|---|---|---|---|
| Publication year | 4.232 | 2.659 | 0.137 |
| Sample size | -0.002 | 0.006 | 0.814 |
Fig 4. Funnel plot to test the publication bias in 15 studies with 95% confidence limits.
Table 3. Sensitivity analysis of pooled prevalence for each study being removed one at a time.
| Study omitted | Publication year | Estimate [95% CI] |
|---|---|---|
| Abebaw T. et al., | 2017 | 20.57(14.00, 27.14) |
| Abeje G. and Azage M. | 2015 | 21.13(14.39, 27.88) |
| Afework G. | 2015 | 21.20(14.53, 27.87) |
| Akibu M. et al. | 2018 | 19.64(13.50, 26.32) |
| Bante A. et al. | 2018 | 16.92(11.83, 22.00) |
| Bedaso A. et al | 2018 | 19.91(13.50, 26.32) |
| Belete T. | 2016 | 20.30(13.81, 26.80) |
| Biset A. and Adugna H. | 2017 | 19.43(13.11, 25.75) |
| Dugassa M., | 2018 | 19.01(12.91, 25.10) |
| Feleke B. | 2016 | 21.28(13.83, 28.73) |
| Girma T. | 2015 | 21.45(14.47, 28.44) |
| Lateef I. | 2018 | 18.61(12.49, 24.74) |
| Mekonnen R. et al. | 2018 | 18.91(12.70, 25.12) |
| Taddesse G. et al., | 2016 | 21.44(14.38, 28.49) |
| Yimer S. et al. | 2017 | 20.87(14.29, 27.44) |
Factors associated with full-dose hepatitis B vaccination coverage among health care workers
Nine variables were extracted to identify factors associated with full-dose hepatitis B vaccination coverage among health care workers. Of these, 5 variables (sex, experience, educational level, training on infection prevention, and history of exposure to blood and body fluids) were found to be significantly associated with full-dose HBV vaccination (Table 4). Depending on the sociodemographic characteristics of the study participants, male health care workers were 35% less likely to take full-dose hepatitis B vaccination than females (OR: 0.65 (95% CI 0.50–0.85), p = 0.002, I2: 44.3%; the heterogeneity test (p = 0.084) showed significant evidence of variation across studies, and Egger’s test showed no evidence of publication bias (p = 0.507)). Additionally, health care workers with an educational level of diploma and below were 53% less likely to take full-dose hepatitis B vaccination than those with an educational level of degree and above (OR: 0.47 (95% CI 0.29–0.77), p = 0.003, I2: 66.8%; the heterogeneity test (p = 0.017) showed no significant variation across studies, and Egger’s test showed no evidence of publication bias (p = 0.363)).
Table 4. Factors associated with full-dose hepatitis B vaccination coverage among health care workers in Ethiopia.
| Determinants (References) | Comparison | Number of studies | Sample size | OR (95% CI) | P value | I2 (%) | Heterogeneity test (P value) | Egger test (P value) |
|---|---|---|---|---|---|---|---|---|
| Sex [27–29, 32, 33, 35, 37, 38] | Male Vs. Female | 8 | 3203 | 0.65 (0.50–0.85) | 0.002 | 44.3 | 0.084 | 0.507 |
| Age [32–35, 37] | <30 Vs. ≥ 30 years | 5 | 1436 | 0.73 (0.48–1.11) | 0.139 | 58.7 | 0.046 | 0.076 |
| Experience [28, 29, 32, 33, 35, 38] | <5 Vs. ≥ 5 years | 6 | 1786 | 0.34 (0.23–0.51) | < 0.001 | 63.6 | 0.017 | 0.090 |
| Profession [27–29, 32, 33, 34] | Nurses Vs. Others | 7 | 3036 | 1.12 (0.60–2.10) | 0.725 | 89.5 | < 0.001 | 0.991 |
| Marital status [27, 28, 32–35, 37, 38] | Married Vs. Others | 8 | 3230 | 1.49 (0.95–2.33) | 0.085 | 80.4 | < 0.001 | 0.365 |
| Educational level [30, 32, 33, 35, 37] | Diploma and below Vs. Degree and above | 5 | 1433 | 0.47 (0.29–0.77) | 0.003 | 66.8 | 0.017 | 0.363 |
| Knowledge on HBV vaccine [28, 35, 37, 38] | Good Vs. Poor | 4 | 1352 | 1.26 (0.46–3.45) | 0.652 | 93 | < 0.001 | 0.218 |
| Training on IP [27, 29, 30, 33, 35, 37] | Yes Vs. No | 6 | 2638 | 2.77 (1.61–4.76) | < 0.001 | 89 | < 0.001 | 0.207 |
| History of exposure [27, 29, 30, 35, 37] | Yes Vs. No | 5 | 2417 | 2.93 (1.55–5.52) | 0.001 | 86.8 | < 0.001 | 0.237 |
Health care providers with less than 5 years of work experience were 66% less likely to take full-dose hepatitis B vaccination than those with more than 5 years of work experience (OR: 0.34 (95% CI 0.23–0.51), p < 0.001, I2: 63.6%; %, the heterogeneity test (p = 0.017) showed no significant variation across studies, and Egger’s test showed no evidence of publication bias (p = 0.090)). Health care providers who received training on infection prevention were almost three times more likely to take full-dose hepatitis B vaccination than those who lacked training (OR: 2.77 (95% CI 1.61–4.76), p < 0.001, I2: 89%; the heterogeneity test (p <0.001) showed no significant variation across studies and Egger’s test showed no evidence of publication bias (p = 0.207)). Those who had a history of exposure to blood and body fluids were almost three times more likely to take full-dose hepatitis B vaccination than those who had not (OR: 2.93 (95% CI (1.55–5.52), p = 0.001, I2: 89%; the heterogeneity test (p <0.001) showed no significant variation across studies, and Egger’s test showed no evidence of publication bias (p = 0.237)) (Table 4).
Discussion
A systematic review and meta-analysis were conducted to estimate the level of full-dose HBV vaccination coverage among healthcare workers and associated factors in Ethiopia. The estimated pooled national prevalence of full-dose hepatitis B vaccination coverage among health care workers in Ethiopia was 20.04% (95% CI 13.83, 26.26). This result is lower than a similar systematic review and meta-analysis conducted in China and America, where the prevalence of vaccination coverage was 60% and 63.4% respectively [18, 22]. This might be due to differences in socioeconomic status and standards of health care services. Our estimate is also lower than other African countries such as Kenya, Nigeria, and Libya [6], but higher than the national prevalence of 11.4% of Cameron [41]. This might be because the cost and unavailability of vaccination might be the reason for the low coverage [6, 17]. Moreover, the tendency to be vaccinated against hepatitis B is increased in workplaces offering a free hepatitis B vaccine for their health care workers [18].
Based on the subgroup analysis, the highest 42.33% and the lowest 12.16 prevalence of HBV full-dose vaccination among healthcare workers was observed in the SNNPR and Amhara region, respectively. In Oromia region pooled prevalence of full-dose hepatitis B vaccination coverage was 18.42% whereas in Addis Ababa the documented prevalence was 14.02%. Difference might be because of the difference in sample size and number of included studies in this meta-analysis. For instance, the highest sample size included in this study was from Amhara region and the lowest number of studies were included from SNNPR.
The results of this meta-analysis should that sex, educational level, work experience, training on infection prevention, and history of exposure to blood and body fluids were significantly associated with full-dose HBV vaccination.
Male health care workers were 35% less likely to take full-dose hepatitis B vaccination than females. This is consistent with study conducted at a tertiary care hospital in India which showed higher vaccination rate among female HCWs [42]. This might be because women have higher risk perception than men, and women are more concerned to their health.
Health care workers having an educational level of diploma and below were 53% less likely to receive full-dose vaccination against hepatitis B as compared to those having an educational level of degree and above. This is consistent with studies conducted in the United States [43] Western Greece [44] and Nigeria [45]. This might be because there is better awareness of the infectious disease and a higher acceptance of vaccination among highly educated health care workers [46].
Health care providers who received training on infection-prevention were almost three times more likely to complete the vaccine than those who had not received it. This is consistent with a study conducted in China [18] and Zambia [47]. This is because the training of health care workers increases their awareness of the importance of being vaccinated against HBV and provides them with relevant information to scale up vaccine uptake since they are a high-risk population for HBV infection [6].
Additionally, this review found that health care workers with work experience of less than 5 years were 66% times less likely to complete full-dose hepatitis vaccination compared to those having work experience of greater than or equal to 5 years. This was in an agreement with a systematic review and meta-analysis performed in Africa among health care workers [6] and a study conducted in Italy [48] and Nigeria [34]. This might be because having a long duration of work experience results in repeated episodes of exposure to blood and body fluids that might assist them looking for vaccination against hepatitis B [6]. Moreover, health care workers who had a history of exposure to blood and body fluids were almost three times more likely to complete vaccination against hepatitis B than those who had no history of exposure. This is consistent with a study conducted in Tanzania [49].
Although this systematic review and meta-analysis provide up-to-date evidence regarding the national full-dose HBV vaccination coverage, there are some limitations that need to be considered in future research. First, the protocol of this study was not registered. Second, this study lacks studies from some regions of Ethiopia (Afar, Benishangul Gumuz, Harari, Somalia, and Tigray), and other regions have limited number of study (Diredawa have only one and SNNPR have two studies), therefore it may be difficult to generalize the findings to the national level. Third, we identified significant heterogeneity across the included studies and the presence of publication bias; thus, the interpretation of the results must be taken cautiously. Lastly, the included studies were based on self-reports of their vaccination status which may introduce recall and social desirability biases.
Conclusions
This study revealed that one in five health care workers received the full-dose of HBV vaccination, which implies that the national full-dose of hepatitis B vaccination coverage among health care workers was low. Sex, educational level, work experience, training on infection prevention, and history of exposure to blood and body fluids were found to be significantly associated with full-dose hepatitis B vaccination coverage. Therefore, training health care workers on infection prevention particularly on hepatitis B, is recommended to increase the uptake of the vaccine. Although, testing HBsAg/anti-HBs for newly recruited health care providers, providing free vaccination for those HBsAg/anti-HBs negative workers, and also testing and providing vaccine every 5 years for those long-term workers is expected form the government and hospital authorities to scale up the utilization.
Supporting information
(DOC)
(XLSX)
Acknowledgments
We would like to thank all authors of the studies included in this systematic review and meta-analysis.
List of abbreviations
- CI
Confidence Interval
- EPI
expanded programme on immunization
- FMOH
Federal Ministry of Health
- HBV
hepatitis B virus
- NOS
Newcastle Ottawa Scale
- OR
Odds Ratio
- PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- SNNP
Southern Nations, Nationalities, and Peoples
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
The authors received no specific funding for this work.
References
- 1.World Health Organization. Hepatitis B. Fact sheet. Available from: http://www.who.int/topics/hepatitis/factsheets/en/.
- 2.Lewis JD, Enfield KB, Sifri CD. Hepatitis B in healthcare workers: Transmission events and guidance for management. World journal of hepatology. 2015. March 27;7(3):488 10.4254/wjh.v7.i3.488 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Joukar F, Mansour-Ghanaei F, Naghipour MR, Asgharnezhad M. Immune responses to single-dose versus double-dose hepatitis B vaccines in healthcare workers not responding to the primary vaccine series: a randomized clinical trial. Hepatitis monthly. 2016. February;16(2). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Shefer A, Atkinson W, Friedman C, Kuhar DT, Mootrey G, Bialek SR, et al. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report: Recommendations and Reports. 2011. November 25;60(7):1–45. [PubMed] [Google Scholar]
- 5.World Health Organization. Global hepatitis report 2017. World Health Organization; 2017. [Google Scholar]
- 6.Auta A, Adewuyi EO, Kureh GT, Onoviran N, Adeloye D. Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis. Vaccine. 2018. August 6; 36(32):4851–60. 10.1016/j.vaccine.2018.06.043 [DOI] [PubMed] [Google Scholar]
- 7.Gerberding JL. Management of occupational exposures to blood-borne viruses. New England Journal of Medicine. 1995. February 16; 332(7):444–51. 10.1056/NEJM199502163320707 [DOI] [PubMed] [Google Scholar]
- 8.Gebremariam AA, Tsegaye AT, Shiferaw YF, Reta MM, Getaneh A. Seroprevalence of hepatitis B virus and associated factors among health professionals in University of Gondar Hospital, Northwest Ethiopia. Advances in preventive medicine. 2019; 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017–Recommendations. Vaccine. 2019 Jan 7;37(2):223–5. [DOI] [PubMed]
- 10.Rapiti E, Prüss-Üstün A, Hutin YJ. Sharps injuries: assessing the burden of disease from sharps injuries to health-care workers at national and local levels. Geneva:; 2005. [DOI] [PubMed]
- 11.Malewezi B, Omer SB, Mwagomba B, Araru T. Protecting health workers from nosocomial Hepatitis B infections: A review of strategies and challenges for implementation of Hepatitis B vaccination among health workers in Sub-Saharan Africa. Journal of epidemiology and global health. 2016. December 1;6(4):229–41. 10.1016/j.jegh.2016.04.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yazie TD, Tebeje MG. An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia. BMC infectious diseases. 2019. December 1;19(1):917 10.1186/s12879-019-4486-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Singh KP, Crane M, Audsley J, Lewin SR. HIV-Hepatitis B virus co-infection: epidemiology, pathogenesis and treatment. AIDS (London, England). 2017. September 24; 31(15):2035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Goa A, Dana T, Bitew S, Arba A. Seroprevalence and associated factors of hepatitis B virus infection among HIV-positive adults attending an antiretroviral treatment clinic at Wolaita Sodo University Referral Hospital. Hepatic Medicine: Evidence and Research. 2019;11:137 10.2147/HMER.S206870 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Federal Ministry of Health (FMoH). ETHIOPIA NATIONAL EXPANDED PROGRAMME ON IMMUNIZATION COMPREHENSIVE MULTI-YEAR PLAN 2016–2020. Available from https://bidinitiative.org/wp-content/files_mf/1405630243EthiopiaComprehensivemultiyearplanfor20112015Year2010.pdf
- 16.Belete H, Kidane T, Bisrat F, Molla M, Mounier-Jack S, Kitaw Y. Routine immunization in Ethiopia. The Ethiopian Journal of Health Development (EJHD). 2015;29(1). [Google Scholar]
- 17.Abiye S, Yitayal M, Abere G, Adimasu A. Health professionals’ acceptance and willingness to pay for hepatitis B virus vaccination in Gondar City Administration governmental health institutions, Northwest Ethiopia. BMC health services research. 2019. December 1;19(1):796 10.1186/s12913-019-4671-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yuan Q, Wang F, Zheng H, Zhang G, Miao N, Sun X, et al. Hepatitis B vaccination coverage among health care workers in China. PloS one. 2019;14(5). 10.1371/journal.pone.0216598 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Federal Ministry of Health (FMOH), Infection prevention guidelines for Healthcare Facilities in Ethiopia. Infection prevention principles, Addis Ababa: Ethiopian Federal Democratic Republic Ministry of Health, 2004.
- 20.Tsega E. Epidemiology, prevention and treatment of viral hepatitis with emphasis on new developments. Ethiopian Medical Journal. 2000. April;38(2):131–41. [PubMed] [Google Scholar]
- 21.Tatsilong HO, Noubiap JJ, Nansseu JR, Aminde LN, Bigna JJ, Ndze VN, et al. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon. BMC Public Health. 2016. December 1;16(1):706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Byrd KK, Lu PJ, Murphy TV. Hepatitis B vaccination coverage among health-care personnel in the United States. Public Health Reports. 2013. November;128(6):498–509. 10.1177/003335491312800609 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100 10.1371/journal.pmed.1000100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One. 2016;11(1):e0147601 10.1371/journal.pone.0147601 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Mak. 2005;25:646–54 10.1177/0272989X05282643 [DOI] [PubMed] [Google Scholar]
- 26.Girma T. Knowledge, Attitude and practice of health care workers towards standard precaution in West Hararghe Hospitals, Oromia Regional State, Ethiopia. J Infect Dis Ther. 2015;3(221):2332–0877. [Google Scholar]
- 27.Feleke BE. Low coverage of hepatitis B vaccine and determinants among health professionals working in Amhara regional state hospitals, Ethiopia. Journal of public health in Africa. 2016. December 31;7(2). 10.4081/jphia.2016.553 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Abebaw TA, Aderaw Z, Gebremichael B. Hepatitis B virus vaccination status and associated factors among health care workers in Shashemene Zonal Town, Shashemene, Ethiopia: a cross sectional study. BMC research notes. 2017. December;10(1):260 10.1186/s13104-017-2582-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Akibu M, Nurgi S, Tadese M, Tsega WD. Attitude and vaccination status of healthcare workers against hepatitis B infection in a teaching hospital, Ethiopia. Scientifica. 2018;2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Dugassa M. Assessment of knowledge about hepatitis b virus infection and vaccination status of health care workers against hepatitis b virus in selected health institutions of East Wollega Zone, West Ethiopia, 2018 (Doctoral dissertation, Addis Ababa University).
- 31.Abeje G, Azage M. Hepatitis B vaccine knowledge and vaccination status among health care workers of Bahir Dar City Administration, Northwest Ethiopia: a cross sectional study. BMC infectious diseases. 2015. December;15(1):30 10.1186/s12879-015-0756-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Biset Ayalew M, Adugna Horsa B. Hepatitis B vaccination status among health care workers in a tertiary hospital in Ethiopia. Hepatitis research and treatment. 2017;2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Afework G. Knowledge, Attitude and Practice of Hepatitis B Virus and Its Vaccination Among Health Care Professionals in Selected Public Hospitals of Addis Ababa, Ethiopia (Doctoral dissertation, Addis Ababa University).
- 34.Belete T. Assessment of Hepatitis B Vaccine Utilization among Health Care Professionals at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia (Doctoral dissertation, Addis Ababa University).
- 35.Lateef I. Risk perception of hepatitis b infection and uptake of hepatitis b vaccine among the nurses in private hospitals in Addis Ababa-a cross-sectional study (Doctoral dissertation, Addis Ababa Universty).
- 36.Taddesse G. Determination of the Magnitude of Hepatitis B Viral Infections in Healthcare Workers in St Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia (Doctoral dissertation, Addis Ababa University).
- 37.Yimer YS, Mohammed MS, Muhammed KM, Tsige Y. Predictors and Vaccination Status of Nurses against Hepatitis B Virus at Public Hospitals in Addis Ababa, Ethiopia. Int J Pub Health Safe. 2017;2(142):2. [Google Scholar]
- 38.Bante A, Debalkie M, Getie A, Wassihun B, Mersha A, Ahmed Y, et al. Hepatitis B vaccination and its associated factors among health care workers working in Wolayita Sodo Hospitals, Southern Ethiopia: a cross-sectional study. Journal of Infectious Diseases and Immunity. 2019. August 31;11(1):1–0. [Google Scholar]
- 39.Bedaso A, Duko B, Fedlu R. Knowledge on HBV vaccine and vaccination status among health care workers of Hawassa University Comprehensive Specialized Hospital, Hawassa, southern Ethiopia: a cross sectional study. BMC research notes. 2018. December 1;11(1):912 10.1186/s13104-018-4023-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mekonnen R, Yosef H, Teklegiorgis K, Tesfaye F, Dagne I. Magnitude and impact of occupational related needle stick and sharp injuries and associated factors among health care workers in Dire Dawa, Eastern Ethiopia. Med Saf Glob Health. 2018;7:2–7. [Google Scholar]
- 41.Bilounga Ndongo C, Eteki L, Siedner M, Mbaye R, Chen J, Ntone R, et al. Prevalence and vaccination coverage of Hepatitis B among healthcare workers in Cameroon: A national seroprevalence survey. Journal of viral hepatitis. 2018. December;25(12):1582–7. 10.1111/jvh.12974 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Rao TV, Suseela IJ, Sathiavathy KA. Estimation of antibodies to HBsAg in vaccinated health care workers. Indian journal of medical microbiology. 2008. January 1;26(1):93 10.4103/0255-0857.38876 [DOI] [PubMed] [Google Scholar]
- 43.Lu PJ, Euler GL. Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States. American journal of infection control. 2011. August 1;39(6):488–94. 10.1016/j.ajic.2010.10.009 [DOI] [PubMed] [Google Scholar]
- 44.Karaivazoglou K, Triantos C, Lagadinou M, Bikas C, Michailidou M, Kalafateli M, et al. Acceptance of hepatitis B vaccination among health care workers in Western Greece. Archives of environmental & occupational health. 2014. April 3;69(2):107–11. 10.1080/19338244.2012.750586 [DOI] [PubMed] [Google Scholar]
- 45.Omotowo IB, Meka IA, Ijoma UN, Okoli VE, Obienu O, Nwagha T, et al. Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria. BMC infectious diseases. 2018. December;18(1):288 10.1186/s12879-018-3191-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Hur K, Wong M, Lee J, Lee J, Juon HS. Hepatitis B infection in the Asian and Latino communities of Alameda County, California. Journal of community health. 2012. October 1;37(5):1119–26. 10.1007/s10900-012-9553-0 [DOI] [PubMed] [Google Scholar]
- 47.Mungandi N, Makasa M, Musonda P. Hepatitis B vaccination coverage and the determinants of vaccination among health care workers in selected health facilities in Lusaka district, Zambia: an exploratory study. Annals of occupational and environmental medicine. 2017. December;29(1):32 10.1186/s40557-017-0191-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Tafuri S, Martinelli D, Caputi G, Arbore A, Lopalco PL, Germinario C, et al. An audit of vaccination coverage among vaccination service workers in Puglia, Italy. American journal of infection control. 2009. June 1;37(5):414–6. 10.1016/j.ajic.2008.10.030 [DOI] [PubMed] [Google Scholar]
- 49.Aaron D, Nagu TJ, Rwegasha J, Komba E. Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much, who and why?. BMC infectious diseases. 2017. December 1;17(1):786 10.1186/s12879-017-2893-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
(DOC)
(XLSX)
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.